RE:RE:ASH December 5 to 8Perhaps a miss-name of the event?
as ONC is clearly reporting as noted bellow:
:Not only are they presenting one-but 3 separate trial results.
That being the week of Dec 5-8th.perhaps being on the 9th confused people as not within the 5-8th week..lol
//stockhouse.com/news/press-releases/2020/11/17/oncolytics-biotech-xae-to-present-aware-1-data-and-provide-updates-on-phase-2
Sanantonio Brest Cancer
Details on the abstracts and corresponding electronic posters are shown below. All posters will be available in a virtual poster hall beginning Wednesday, December 9, 2020 at 9:00 AM ET. Poster Number: PS12-08
Title: A window-of-opportunity study with atezolizumab and the oncolytic virus pelareorep in early breast cancer (REO-027, AWARE-1)
Session Name: Poster Session 12
Presenter: Dr. Luis Manso
Poster Number: OT-13-02
Title: Bracelet-1 (pre0113): a study to assess overall response rate by inducing an inflammatory phenotype in metastatic breast cancer with the oncolytic reovirus pelareorep in combination with anti-PD-L1 avelumab and paclitaxel
Session Name: Ongoing Trials Posters
Presenter: Dr. Kathy Miller
Poster Number: OT-32-02
Title: Irene study: phase 2 study of incmga00012 (retifanlimab) and the oncolytic virus pelareorep in metastatic triple negative breast cancer
Session Name: Ongoing Trials Posters
Presenter: Dr. Mridula George